Drug Delivery: Faculty and Staff
Kristy Ainslie, PhD
The Ainslie Lab focuses on modulation of immune responses to prevent and treat cancer, infectious and autoimmune diseases.
Owen Fenton, PhD
The Fenton Laboratory seeks to develop synthetic drug delivery platforms using RNA therapeutics.
Shawn Hingtgen, PhD
The Hingtgen lab develops engineered stem cell-based therapies for brain cancers and other tumors.
Alexander “Sasha” Kabanov, PhD
The Kabanov lab focuses on nanomedicines for delivery of small drugs, nucleic acids and polypeptides to treat cancers and diseases of the central nervous system.
Sam Lai, PhD
The Lai lab focuses on infectious diseases at mucosal surfaces, targeted drug delivery and nanoparticle-immune interactions.
Juliane Nguyen, PhD
The Nguyen lab focuses on developing genetically encoded and genetically engineered biotherapeutics for the treatment of cancer, myocardial infarction, colitis, and other diseases.
Mark Schoenfisch, PhD
The Schoenfisch lab focuses on designing macromolecules for nitric oxide release and detection, glucose monitoring devices for diabetes and superhydrophobic interfaces.
Phil Smith, PhD
The Smith lab establishes quantitative methods for proteins associated with drug disposition, pharmacokinetics, reactivity and potential toxicity of metabolites.
Learn more about Pharmacoengineering and Molecular Pharmaceutics
Soumya Rahima Benhabbour, PhD
Associate Professor
UNC/NCSU Joint Department of Biomedical Engineering at UNC Chapel Hill
Paul Dayton, PhD
William R. Kenan Distinguished Professor and Chair
UNC/NCSU Joint Department of Biomedical Engineering at UNC Chapel Hill
Weili Lin, PhD
Dixie Lee Boney Soo Distinguished Professor
UNC School of Medicine – Department of Neurology
Eric Bachelder, PhD
Bachelder focuses on the development of biomaterials for the treatment of diseases associated with the immune system.
Elena Batrakova, PhD
The main focus of Batrakova’s research is to develop a CNS delivery system for neurodegenerative disorders, such as Parkinson’s and Alzheimer’s diseases.
Jillian Perry, PhD
Jillian Perry, PhD, leverages her knowledge of polymer chemistry, biomaterials, and drug delivery to develop novel drug delivery carriers for the treatment of cancer and infectious diseases.
Marina Sokolsky, PhD
Sokolsky-Papkov’s current research centers on design of nano-based, sustained release and remote actuated drug delivery systems for treatment and diagnosis of cancer.
John Fallon, PhD
Fallon’s research focuses on quantitative targeted proteomics (QTAP) using nano- and microLC-MS/MS.
